IBM announces deals with Apple, Johnson & Johnson, Medtronic to bring Watson into healthcare
Matthew Herper / Forbes :
Context & Ripple Effects
This announcement lands two months after Apple built a dedicated US sales team for its IBM partnership aimed at healthcare among other industries — so today's deal gives that enterprise alliance a concrete healthcare product to sell. It is also the opening move of IBM's campaign to turn Watson, until now a research showcase, into a revenue platform inside regulated industries.
The arc that follows is visible in the related coverage: within months IBM pays $1 billion for Merge Healthcare to add medical imaging data to Watson, extends the same partnership template to consumer brands like Softbank Robotics, Whirlpool and Under Armour, and by late 2016 execs are telling the Times the years of heavy Watson investment are finally yielding profitable opportunities in healthcare and manufacturing.
First-order effects
- Johnson & Johnson and Medtronic become Watson's first named healthcare customers, embedding cognitive computing into their clinical and device workflows, while Apple gains a flagship healthcare vertical for its joint IBM enterprise sales effort.
- IBM converts Watson from a demo asset into a contracted product line, giving its healthcare sales teams reference deals at two of the largest names in medicine.
Second-order effects
- Because these deals depend on medical data Watson does not yet have, IBM moves to acquire it outright — the $1 billion Merge Healthcare purchase brings diagnostic imaging under Watson months later.
- The partnership template proves portable: IBM replicates the co-development structure with Softbank Robotics, Whirlpool and Under Armour, pushing Watson beyond healthcare into consumer and industrial markets.
Third-order effects
- If the pattern holds, incumbent IT vendors compete for AI positioning less on their own algorithms than on exclusive data pipelines and distribution deals with industry incumbents — which is why IBM keeps paying for data assets like Merge while leaning on Apple's enterprise channel.
- Healthcare becomes the proving ground where AI credibility gets established: once device makers like Medtronic ship Watson-powered products, 'cognitive' becomes a procurement requirement across the supplier base rather than a marketing term.
The trend: Enterprise AI is being commercialized through alliances that pair a tech vendor's cognitive platform with industry incumbents' data and distribution, with healthcare as the first beachhead.